Apyx Medical Dirección
Dirección controles de criterios 3/4
El CEO de Apyx Medical's es Charlie Goodwin , nombrado en Dec 2017, tiene una permanencia de 6.33 años. compensación anual total es $1.26M, compuesta por 38.2% salario y 61.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.26% de las acciones de la empresa, por valor de $133.20K. La antigüedad media del equipo directivo y de la junta directiva es de 5.8 años y 6.8 años, respectivamente.
Información clave
Charlie Goodwin
Chief Executive Officer (CEO)
US$1.3m
Compensación total
| Porcentaje del salario del CEO | 38.2% |
| Permanencia del CEO | 6.3yrs |
| Participación del CEO | 0.3% |
| Permanencia media de la dirección | 5.8yrs |
| Promedio de permanencia en la Junta Directiva | 6.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Revenues Working Against Apyx Medical Corporation's (NASDAQ:APYX) Share Price Following 25% Dive
Apr 18
Apyx Medical Corporation (NASDAQ:APYX) Analysts Just Slashed This Year's Estimates
Mar 26Take Care Before Diving Into The Deep End On Apyx Medical Corporation (NASDAQ:APYX)
Feb 16Is Apyx Medical (NASDAQ:APYX) A Risky Investment?
Sep 14Does Apyx Medical (NASDAQ:APYX) Have A Healthy Balance Sheet?
Jun 07Forecast: Analysts Think Apyx Medical Corporation's (NASDAQ:APYX) Business Prospects Have Improved Drastically
Mar 21Here's Why We're Watching Apyx Medical's (NASDAQ:APYX) Cash Burn Situation
Dec 14We're Not Very Worried About Apyx Medical's (NASDAQ:APYX) Cash Burn Rate
Aug 30Apyx Medical GAAP EPS of -$0.16 beats by $0.03, revenue of $10.3M misses by $0.26M
Aug 11Apyx Medical gets FDA nod for Renuvion's use in improving loose skin on neck, chin
Jul 18Companies Like Apyx Medical (NASDAQ:APYX) Are In A Position To Invest In Growth
May 26Are Investors Undervaluing Apyx Medical Corporation (NASDAQ:APYX) By 42%?
Mar 15We Think Apyx Medical (NASDAQ:APYX) Can Easily Afford To Drive Business Growth
Jan 08We Think Apyx Medical (NASDAQ:APYX) Can Easily Afford To Drive Business Growth
Sep 28Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | US$1m | US$483k | -US$19m |
| Sep 30 2023 | n/a | n/a | -US$15m |
| Jun 30 2023 | n/a | n/a | -US$16m |
| Mar 31 2023 | n/a | n/a | -US$21m |
| Dec 31 2022 | US$2m | US$483k | -US$23m |
| Sep 30 2022 | n/a | n/a | -US$19m |
| Jun 30 2022 | n/a | n/a | -US$18m |
| Mar 31 2022 | n/a | n/a | -US$16m |
| Dec 31 2021 | US$2m | US$450k | -US$15m |
| Sep 30 2021 | n/a | n/a | -US$15m |
| Jun 30 2021 | n/a | n/a | -US$14m |
| Mar 31 2021 | n/a | n/a | -US$15m |
| Dec 31 2020 | US$2m | US$450k | -US$12m |
| Sep 30 2020 | n/a | n/a | -US$16m |
| Jun 30 2020 | n/a | n/a | -US$16m |
| Mar 31 2020 | n/a | n/a | -US$16m |
| Dec 31 2019 | US$2m | US$450k | -US$20m |
| Sep 30 2019 | n/a | n/a | -US$18m |
| Jun 30 2019 | n/a | n/a | -US$15m |
| Mar 31 2019 | n/a | n/a | -US$14m |
| Dec 31 2018 | US$1m | US$400k | -US$11m |
| Sep 30 2018 | n/a | n/a | -US$10m |
| Jun 30 2018 | n/a | n/a | -US$12m |
| Mar 31 2018 | n/a | n/a | -US$15m |
| Dec 31 2017 | US$2m | US$15k | -US$14m |
Compensación vs. Mercado: La compensación total de Charlie($USD1.26M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD668.06K).
Compensación vs. Ingresos: La compensación de Charlie ha sido consistente con los resultados de la empresa en el último año.
CEO
Charlie Goodwin (56 yo)
6.3yrs
Permanencia
US$1,261,470
Compensación
Mr. Charles D. Goodwin II, also known as Charlie, has been Chief Executive Officer and Director of Apyx Medical Corporation (formerly known as Bovie Medical Corporation) since December 15, 2017 and serves...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 6.3yrs | US$1.26m | 0.26% $ 128.7k | |
| CFO, Treasurer & Secretary | less than a year | US$445.95k | 0.0072% $ 3.6k | |
| Senior Vice President | 12.3yrs | US$538.31k | 1.32% $ 652.8k | |
| Executive Vice President | 5.3yrs | US$746.27k | 0% $ 0 |
5.8yrs
Permanencia media
55yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de APYX es experimentado (5.8 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 6.3yrs | US$1.26m | 0.26% $ 128.7k | |
| Independent Chairman of the Board | 41.3yrs | US$124.06k | 1.8% $ 892.9k | |
| Independent Director | 13.1yrs | US$114.06k | 0.079% $ 39.3k | |
| Lead Independent Director | 13.1yrs | US$162.56k | 0.12% $ 61.3k | |
| Member of Medical Advisory Board | 4.8yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | US$9.30k | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Vice-Chairman of the Board | 9.8yrs | US$144.06k | 0% $ 0 | |
| Independent Director | 4.7yrs | US$116.56k | 0% $ 0 | |
| Independent Director | 6.1yrs | US$106.56k | 0.17% $ 86.0k | |
| Member of Medical Advisory Board | 7.3yrs | sin datos | sin datos | |
| Member of Medical Advisory Board | 5.9yrs | sin datos | sin datos |
6.8yrs
Permanencia media
69yo
Promedio de edad
Junta con experiencia: La junta directiva de APYX se considera experimentada (6.8 años de antigüedad promedio).